Currently, there are 52.03M common shares owned by the public and among those 30.44M shares have been available to trade.
The company’s stock has a 5-day price change of 104.20% and 115.97% over the past three months. GHRS shares are trading 157.00% year to date (YTD), with the 12-month market performance up to 137.02% higher. It has a 12-month low price of $6.00 and touched a high of $14.99 over the same period. GHRS has an average intraday trading volume of 79.26K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 90.78%, 106.09%, and 80.79% respectively.
Institutional ownership of GH Research PLC (NASDAQ: GHRS) shares accounts for 57.82% of the company’s 52.03M shares outstanding.
It has a market capitalization of $935.99M and a beta (3y monthly) value of 0.94. The earnings-per-share (ttm) stands at -$0.80. Price movements for the stock have been influenced by the stock’s volatility, which stands at 9.51% over the week and 10.01% over the month.
Earnings per share for the fiscal year are expected to decrease by -18.14%, and -29.67% over the next financial year. EPS should grow at an annualized rate of -20.39% over the next five years, compared to -253.12% over the past 5-year period.
Looking at the support for the GHRS, a number of firms have released research notes about the stock. H.C. Wainwright stated their Buy rating for the stock in a research note on August 16, 2022, with the firm’s price target at $45. ROTH Capital coverage for the GH Research PLC (GHRS) stock in a research note released on June 16, 2022 offered a Buy rating with a price target of $66.
